Technetium Tc-99m tilmanocept Completed Phase 2 Trials for Malignant Neoplasm of Colon / Rectal Carcinoma Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT01902953Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)